Protocol Number | Type of Cancer or Study | Intergroup Number | Coordinating Center | Study Status | Closure Date | Treatment Credit | Cancer Control Credit | Followup Credit | Followup Years | Credit Description |
---|---|---|---|---|---|---|---|---|---|---|
62933 | Sarcoma | 62933 | EORTC | CL | 10/15/2000 | 1 | 0 | 0 | EORTC is Coordinating Group | |
89803 | Gastrointestinal | C89803 | CALGB | CL | 5/15/2001 | 1 | 0 | 0 | ||
ACOSOG-Z9000 | Gastrointestinal | ACOSOG-Z9000 | CTSU | CL | 9/26/2003 | 1 | 0 | 0 | 0 | |
ACOSOG-Z9001 | Gastrointestinal | ACOSOG-Z9001 | CTSU | CL | 4/18/2007 | 1 | 0 | 0 | 0 | |
AEWS0031 | Sarcoma | AEWS0031 | COG | CL | 8/6/2005 | 1 | 0 | 0 | 0 | |
BMTCTN-0102 | Other | SWOG | CL | 3/30/2007 | 1 | 0.5 | 0 | 0 | Cancer Control credit for QOL | |
BMTCTN-0401 | Lymphomas Non-Hodgkin's | SWOG | AC | 1 | 0 | 0 | 0 | |||
C19807 | Leukemia, Chronic | C19807 | CALGB | CL | 5/15/2001 | 1 | 0 | 0 | ||
C80002 | Gastrointestinal | CALGB-80002 | CALGB | CL | 8/29/2003 | 1 | 0 | 0 | 0 | |
C90003 | Genitourinary | CALGB-90003 | CALGB | CL | 4/15/2004 | 1 | 0 | 0 | 0 | |
C9581(S) | Gastrointestinal | CALGB | CL | 5/31/2002 | 1.1 | 0 | 0 | 0 | 0.1 CREDIT FOR MARKER STUDY | |
C9732(S) | Lung | C9732 | CALGB | CL | 7/13/2001 | 1 | 0 | 0 | ||
C9741(S) | Breast | C9741 | CALGB | CL | 3/31/1999 | 1 | 0 | 0 | 0 | |
CALGB-10404 | Leukemia, Chronic | CALGB-10404 | CALGB | AC | 1 | 0 | 0 | 0 | ||
CALGB-19801 | Leukemia, Acute | CALGB-19801 | CALGB | CL | 9/12/2001 | 1 | 0 | 0 | ||
CALGB-30102 | Lung | CALGB-30102 | CALGB | CL | 12/28/2004 | 1 | 0.3 | 0 | 0 | Cancer Control credit for QOL |
CALGB-40101 | Breast | CALGB-40101 | CALGB | AC | 1 | 0 | 0 | |||
CALGB-49907 | Breast | CALGB-49907 | CALGB | CL | 12/29/2006 | 1 | 0.2 | 0 | 0 | Assignment changed to 0.2 CC credits for sites and research base. Original assignment = 0.5 cc credit for QOL to the CALGB Research Base only. |
CALGB-80101 | Gastric | CALGB-80101 | CALGB | AC | 1 | 0 | 0 | 0 | ||
CALGB-9687 | Genitourinary | CALGB-9687 | CALGB | CL | 2/15/2003 | 1 | 0 | 0 | ||
CALGB-9710 | Leukemia, Acute | CALGB-9170 | CALGB | CL | 3/29/2005 | 1 | 0 | 0 | ||
E1199 | Breast | E1199 | ECOG | CL | 1/8/2002 | 1 | 0 | 0 | ||
E1295(S) | Gastrointestinal | E1295 | ECOG | CL | 2/15/1999 | 0 | 0.5 | 0 | 0 | |
E1395(S) | Head and Neck | E1395 | ECOG | CL | 1/12/2000 | 1 | 0 | 0 | ||
E1695 | Melanoma | E1695 | ECOG | CL | 10/15/1999 | 0.1 | 0 | 0 | ||
E1697 | Melanoma | E1697 | ECOG | AC | 1 | 0.5 | 0 | 0 | 0.5 Cancer Control credit is for QOL | |
E1899 | Genitourinary | E1899 | ECOG | CL | 12/28/2004 | 1 | 0 | 0 | 0 | |
E1905 | Leukemia, Acute | E1905 | ECOG | AC | 1 | 0 | 0 | 0 | ||
E1A02 | Other | E1A02 | ECOG | CL | 4/26/2007 | 1 | 0 | 0 | 0 | |
E1A95(S) | Multiple Myeloma | EA195 | ECOG | CL | 6/15/1999 | 1 | 0 | 0 | 0 | INTERGROUP W/ECOG;SWOG;CALGB & NCIC |
E1D96 | Immunosuppressive Disorders | E1D96 | ECOG | CL | 12/15/2000 | 1 | 0.5 | 0 | 0 | 0.5 CC Credit for QOL |
E2100 | Breast | E2100 | ECOG | CL | 5/26/2004 | 1 | 0 | 0 | 0 | No Cancer Control credit for QOL |
E2197(S) | Breast | E2197 | ECOG | CL | 1/21/2000 | 1 | 0 | 0 | 0 | |
E2496(S) | Lymphomas, Hodgkin's Disease | E2496 | ECOG | CL | 6/15/2006 | 1 | 0 | 0 | 0 | |
E2697 | Melanoma | E2697 | ECOG | CL | 4/18/2002 | 0.1 | 0 | 0 | Correlative Study | |
E2997 | Leukemia, Chronic | E2997 | ECOG | CL | 3/19/2004 | 1 | 0 | 0 | 0 | |
E2998 | Leukemia, Acute | E2998 | ECOG | CL | 10/1/2001 | 1 | 0 | 0 | ||
E3695(S) | Melanoma | E3695 | ECOG | CL | 4/17/2002 | 1 | 0 | 0 | 0 | |
E4397 | Brain | E4397 | ECOG | CL | 11/15/2003 | 1 | 0 | 0 | ||
E4494 | Lymphomas Non-Hodgkin's | E4494 | ECOG | CL | 7/12/2001 | 1 | 0 | 0 | ||
E4697 | Melanoma | E4697 | ECOG | CL | 10/31/2006 | 1 | 0 | 0 | ||
E5597 | Intervention Study | E5597 | Active | 1 | 0.3 | |||||
E8892(S) | Genitourinary | E8892 | ECOG | CL | 5/27/1998 | 1 | 0.5 | 0 | 0 | INTERGROUP STUDY WITH ECOG;SWOG & CALGB CC CREDIT FOR QOL |
E8897 | Genitourinary | E8897 | ECOG | CL | 12/28/2004 | 0.1 | 0 | 0 | ||
EORTC-30904 | Other | EORTC-30904 | CL | 1/13/2003 | 1 | 0 | 0 | |||
EORTC-30987 | Genitourinary | EORTC-30987 | SWOG | CL | 6/1/2004 | 1 | 0 | 0 | ||
G0137 | Gynecologic | GOG-137A | GOG | CL | 1/20/2003 | 0.5 | 0.5 | 0 | 0 | 0.5 RX CREDIT & 0.5 CC CREDIT |
GOG-0182 | Gynecologic | GOG-0182 | GOG | CL | 9/1/2004 | 1 | 0 | 0 | ||
GOG-164(S) | Gynecologic | GOG-164 | GOG | CL | 6/1/1999 | 1 | 0 | 0 | 0 | |
GOG-175 | Gynecologic | GOG-175 | GOG | CL | 8/15/2003 | 1 | 0 | 0 | 0 | |
IBCSG-24-02 | Breast | IBCSG-24-02 | CTSU | AC | 1 | 0.5 | 0 | 0 | 0.5 Cancer Control credit for QOL | |
IBCSG-25-02 | Breast | IBCSG-25-02 | CTSU | CL | 11/30/2007 | 1 | 0.5 | 0 | 0 | 0.5 Cancer Control credit for QOL |
JBR10(S) | Lung Non-Small Cell | JBR10 | NCIC | CL | 4/30/2001 | 1.1 | 0 | 0 | 0 | INCLUDES COMPANION TUMOR MARKER EVALUATION |
JPR.7 | Genitourinary | JPR.7 | NCIC | CL | 11/30/2005 | 1 | 0.5 | 0 | 0 | 0.5 CC CREDIT FOR QOL |
JPR3 | Genitourinary | T94-0110 | NCIC | CL | 8/31/2005 | 1 | 0 | 0 | ||
MA.17(S) | Breast | MA.17 | NCIC | CL | 8/31/2002 | 1 | 0.5 | 0 | 0 | 0.5 CC CREDIT FOR QOL |
MDA-3410 | Genitourinary | MDA-3410 | MDA | AC | 1 | 0 | 0 | 0 | ||
N0426 | Lung Non-Small Cell | N0426 | NCCTG | CL | 2/23/2007 | 1 | 0 | 0 | 0 | |
N9741 | Gastrointestinal | N9741 | NCCTG | CL | 7/18/2002 | 1 | 0.3 | 0 | 0 | 0.3 CC Credit for QOL |
N9831 | Breast | N9831 | NCCTG | CL | 4/30/2005 | 1 | 0 | 0 | ||
N9841 | Gastrointestinal | N9841 | NCCTG | CL | 12/17/2003 | 1 | 0.5 | 0 | 0 | CC Credit is for QOL component |
NCIC-BR.19 | Lung Non-Small Cell | NCIC-BR.19 | CTSU | CL | 4/22/2005 | 1 | 0 | 0 | 0 | |
NCIC-MA.20 | Breast | NCIC-MA.20 | CTSU | CL | 2/2/2007 | 1 | 0 | 0 | 0 | No Credit for QOL since CTSU sites (including CCOPs) will not participate in this component of the study |
NCIC-MA.21 | Breast | NCIC-MA.21 | CTSU | CL | 4/29/2005 | 1 | 0 | 0 | 0 | No Credit for QOL since CTSU sites (including CCOPs) will not participate in this component of the trial |
NCIC-MA.27 | Breast | NCIC-MA.27 | CTSU | AC | 1 | 0 | 0 | 0 | ||
NCIC-PR.11 | Genitourinary | NCIC-PR.11 | CALGB | AC | 1 | 0.5 | 0 | 0 | 0.5 Cancer Control credit for QOL component of trial | |
NSABP B-30 | Breast | NSABP-B-30 | NSABP | CL | 3/31/2004 | 1 | 0.5 | 0 | 0 | 0.5 Cancer Control credit for QOL |
NSABP B-33 | Breast | NSABP-B-33 | NSABP | CL | 10/9/2003 | 1 | 0.5 | 0 | 0 | 0.5 Cancer Control credit for QOL |
NSABP B-34 | Breast | NSABP B-34 | NSABP | CL | 3/31/2004 | 1.2 | 0 | 0 | 0 | |
NSABP B-35 | Breast | NSABP-B-35 | NSABP | CL | 6/15/2006 | 1.1 | 0.3 | 0 | 0 | 0.3 Cancer Control credit for QOL |
R0214 | Lung Non-Small Cell | RTOG-0214 | RTOG | CL | 8/30/2007 | 1 | 0.5 | 0 | 0 | 0.5 Cancer Control credit for QOL |
R9704(S) | Pancreatic | R9704 | RTOG | CL | 7/26/2002 | 1 | 0 | 0 | ||
R9804 | Breast | RTOG 98-04 | RTOG | CL | 7/14/2006 | 1 | 0 | 0 | 0 | |
R9811(S) | Gastrointestinal | INT-0157 | RTOG | CL | 6/27/2005 | 1 | 0 | 0 | 0 | |
R9813 | Brain | RTOG 98-13 | RTOG | CL | 3/30/2007 | 1 | 0 | 0 | 0 | No CC Credit for the QOL - only assessing toxicity differences |
RTOG 98-02(S) | CNS, Pituitary | RTOG 98-02 | RTOG | CL | 6/27/2002 | 1 | 0 | 0 | 0 | |
RTOG-0212 | Lung | RTOG-0212 | RTOG | CL | 3/3/2008 | 1 | 0.5 | 0 | 0 | 0.5 Cancer Control credit for QOL |
RTOG-0412-SWOG-S0332 | Lung Non-Small Cell | RTOG-0412-SWOG-S0332 | RTOG | CL | 12/1/2006 | 1 | 0.5 | 0 | 0 | 0.5 Cancer Control credit for QOL |
RTOG-P-0014 | Genitourinary | RTOG-P-0014 | RTOG | CL | 2/4/2005 | 1 | 0 | 0 | 0 | |
S0000 | Intervention Study | S0000 | Closed | 6/24/2004 | 1 | 0.3 | ||||
S0000A | Intervention Study | Active | 0 | 0 | This study is funded by NIA and therefore no credit is assigned | |||||
S0000B | Descriptive | Active | 0 | This ancillary study is funded by the NEI therefore no credit is assigned. | ||||||
S0000C | Closed | 5/1/2007 | 0 | This ancillary study is funded by NHLBI therefore no credit is assigned | ||||||
S0001 | Brain | SWOG | CL | 11/15/2005 | 1 | 0 | 0 | |||
S0002 | Intervention Study | S0002 | Closed | 1/1/2004 | 1 | Credit Assignment increased from original 0.7 CC Credit upto 1.0 CC Credit | ||||
S0003 | Lung Non-Small Cell | S0003 | SWOG | CL | 11/15/2002 | 1 | 0 | 0 | ||
S0004 | Other | SWOG | CL | 4/1/2002 | 1 | 0 | 0 | |||
S0007 | Head and Neck | SWOG | CL | 3/31/2004 | 1 | 0 | 0 | |||
S0008 | Melanoma | S0008 | SWOG | CL | 11/15/2007 | 1 | 0 | 0 | ||
S0009 | Gynecologic | SWOG | CL | 2/1/2006 | 1 | 0 | 0 | |||
S0010 | Leukemia, Acute | SWOG | CL | 11/1/2003 | 1 | 0 | 0 | |||
S0011 | Head and Neck | SWOG | CL | 7/1/2006 | 1 | 0 | 0 | 0 | ||
S0012 | Breast | S0012 | SWOG | CL | 12/1/2005 | 1 | 0 | 0 | ||
S0013 | Gynecologic | SWOG | CL | 11/15/2003 | 0.2 | 0 | 0 | 0 | ||
S0014 | Lymphomas Non-Hodgkin's | SWOG | CL | 1/15/2002 | 1 | 0 | 0 | |||
S0016 | Lymphomas | S0016 | SWOG | AC | 1 | 0 | 0 | 0 | ||
S0019 | Lymphomas | SWOG | CL | 12/15/2001 | 1 | 0 | 0 | |||
S0020 | Other | S0020 | SWOG | CL | 5/15/2003 | 1 | 0 | 0 | ||
S0022 | Lung Non-Small Cell | SWOG | CL | 2/1/2003 | 1 | 0 | 0 | |||
S0023 | Lung Non-Small Cell | S0023 | SWOG | CL | 4/15/2005 | 1 | 0 | 0 | ||
S0025 | Gynecologic | SWOG | CL | 3/31/2004 | 1 | 0 | 0 | |||
S0026 | Melanoma | SWOG | CL | 5/1/2003 | 1 | 0 | 0 | 0 | ||
S0027 | Lung Non-Small Cell | SWOG | CL | 7/1/2003 | 0.5 | 0.5 | 0 | 0 | Credit Assignment Changed from 1.0 RX to 0.5 RX and 0.5 Cancer Control (CC) for the QOL component. | |
S0028 | Genitourinary | SWOG | CL | 12/15/2006 | 1 | 0.2 | 0 | 0 | 0.2 Cancer Control credit for QOL feasibility | |
S0029 | Breast | SWOG | CL | 6/15/2005 | 1 | 0.2 | 0 | 0 | 0.2 Cancer Control credit for QOL feasibility | |
S0030 | Gastrointestinal | SWOG | CL | 2/1/2005 | 1 | 0.2 | 0 | 0 | 0.2 Cancer Control Credit for QOL feasibility | |
S0031 | Genitourinary | SWOG | CL | 10/15/2002 | 1 | 0 | 0 | |||
S0032 | Genitourinary | SWOG | CL | 6/1/2005 | 1 | 0 | 0 | |||
S0033 | Other | S0033 | SWOG | CL | 9/1/2001 | 1 | 0 | 0 | ||
S0101 | Gastrointestinal | SWOG | CL | 2/1/2003 | 1 | 0 | 0 | |||
S0102 | Breast | SWOG | CL | 1/1/2004 | 1 | 0 | 0 | 0 | ||
S0106 | Leukemia, Acute | S0106 | SWOG | AC | 1 | 0 | 0 | |||
S0107 | Gastrointestinal | SWOG | CL | 6/1/2003 | 1 | 0 | 0 | |||
S0108 | Lymphomas Non-Hodgkin's | SWOG | CL | 12/1/2004 | 1 | 0 | 0 | |||
S0109 | Genitourinary | SWOG | CL | 2/1/2002 | 1 | 0 | 0 | |||
S0111 | Genitourinary | SWOG | CL | 11/15/2003 | 1 | 0 | 0 | 0 | ||
S0112 | Leukemia, Acute | SWOG | CL | 4/1/2003 | 1 | 0 | 0 | |||
S0115 | Other | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0116 | Melanoma | SWOG | CL | 2/15/2004 | 1 | 0 | 0 | |||
S0117 | Leukemia, Acute | SWOG | CL | 10/15/2005 | 1 | 0 | 0 | |||
S0119 | Lung Non-Small Cell | SWOG | CL | 2/15/2003 | 1 | 0 | 0 | |||
S0120 | Other | SWOG | AC | 0.1 | 0 | 0 | ||||
S0121 | Genitourinary | SWOG | CL | 6/1/2005 | 1 | 0 | 0 | 0 | ||
S0122 | Lung | SWOG | CL | 5/15/2003 | 1 | 0 | 0 | |||
S0124 | Lung Non-Small Cell | S0124 | SWOG | CL | 3/1/2007 | 1 | 0 | 0 | ||
S0125 | Leukemia, Acute | SWOG | CL | 6/1/2005 | 1 | 0 | 0 | 0 | ||
S0126 | Lung Non-Small Cell | SWOG | CL | 7/1/2003 | 1 | 0 | 0 | 0 | ||
S0127 | Gastric | SWOG | CL | 8/15/2003 | 1 | 0 | 0 | |||
S0200 | Gynecologic | S0200 | SWOG | CL | 12/15/2004 | 1 | 0 | 0 | ||
S0202 | Gastrointestinal | SWOG | CL | 4/1/2005 | 1 | 0 | 0 | 0 | ||
S0204 | Other | SWOG | CL | 10/15/2005 | 1 | 0 | 0 | |||
S0205 | Gastrointestinal | S0205 | SWOG | CL | 4/1/2006 | 1 | 0.5 | 0 | 0 | 0.5 Cancer Control credit for QOL |
S0207 | Genitourinary | SWOG | CL | 3/1/2005 | 1 | 0 | 0 | 0 | ||
S0211 | Gynecologic | SWOG | CL | 1/1/2006 | 1 | 0 | 0 | |||
S0213 | Lymphomas | SWOG | CL | 9/1/2006 | 1 | 0 | 0 | |||
S0215 | Breast | SWOG | CL | 1/1/2007 | 1 | 0 | 0 | |||
S0216 | Head and Neck | SWOG | CL | 8/15/2004 | 1 | 0 | 0 | 0 | ||
S0217 | Head and Neck | SWOG | CL | 1/10/2007 | 1 | 0 | 0 | |||
S0218 | Other | SWOG | CL | 4/1/2003 | 1 | 0 | 0 | |||
S0219 | Genitourinary | SWOG | CL | 12/15/2006 | 1 | 0 | 0 | |||
S0220 | Lung Non-Small Cell | S0220 | SWOG | CL | 10/1/2007 | 1 | 0 | 0 | 0 | |
S0221 | Breast | S0221 | SWOG | AC | 1 | 0 | 0 | 0 | ||
S0222 | Lung | SWOG | CL | 7/24/2006 | 1 | 0 | 0 | 0 | ||
S0224 | Genitourinary | S0224 | SWOG | CL | 11/15/2005 | 1 | 0 | 0 | ||
S0226 | Breast | S0226 | SWOG | AC | 1 | 0 | 0 | 0 | ||
S0227 | Gynecologic | S0227 | SWOG | CL | 7/28/2003 | 1 | 0 | 0 | ||
S0229 | Active | 0 | 1 | 0 | ||||||
S0230 | Intervention Study | S0230 | Active | 0 | 1 | 0 | Protocol originally awarded Treatment credit in error. | |||
S0232 | Other | SWOG | CL | 5/11/2007 | 1 | 0 | 0 | 0 | ||
S0300 | Intervention Study | Active | 0 | 1 | 0 | |||||
S0301 | Leukemia, Acute | SWOG | CL | 12/15/2006 | 1 | 0 | 0 | 0 | ||
S0303 | Gastrointestinal | SWOG | CL | 9/1/2004 | 1 | 0.5 | 0 | 0 | 0.5 Cancer Control credit for QOL | |
S0304 | Gastrointestinal | SWOG | CL | 2/1/2006 | 1 | 0 | 0 | 0 | ||
S0306 | Genitourinary | SWOG | CL | 2/1/2007 | 1 | 0 | 0 | 0 | ||
S0307 | Breast | S0307 | SWOG | AC | 1 | 0 | 0 | 0 | ||
S0309 | Other | SWOG | AC | 0 | 0 | 0 | 0 | NO Credit Assignes | ||
S0310 | Lung | SWOG | CL | 8/19/2005 | 1 | 0 | 0 | 0 | No Cancer Control credit for QOL- the difference between the 2 arms unlikely to show significant effect. | |
S0312 | Genitourinary | SWOG | CL | 8/15/2005 | 1 | 0 | 0 | |||
S0313 | Lymphomas Non-Hodgkin's | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0317 | Genitourinary | S0317 | SWOG | CL | 12/15/2005 | 1 | 0 | 0 | 0 | |
S0322 | Head and Neck | SWOG | CL | 2/15/2005 | 1 | 0 | 0 | 0 | ||
S0325 | Leukemia, Chronic | S0325 | SWOG | AC | 1 | 0 | 0 | 0 | ||
S0327 | Lung | SWOG | CL | 9/15/2004 | 1 | 0 | 0 | 0 | ||
S0329 | Head and Neck | SWOG | CL | 1/1/2007 | 1 | 0 | 0 | |||
S0330 | Sarcoma | S0330 | SWOG | CL | 1/15/2006 | 1 | 0 | 0 | 0 | |
S0331 | Other | S0331 | SWOG | CL | 4/1/2007 | 1 | 0 | 0 | 0 | |
S0333 | Leukemia, Acute | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0334 | Other | SWOG | CL | 6/15/2007 | 0 | 0 | 0 | 0 | NO Credit Assigned | |
S0336 | Gastrointestinal | SWOG | CL | 9/1/2005 | 1 | 0 | 0 | 0 | ||
S0337 | Genitourinary | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0338 | Breast | SWOG | CL | 12/1/2005 | 1 | 0 | 0 | 0 | ||
S0339 | Lung Non-Small Cell | SWOG | CL | 10/1/2004 | 1 | 0 | 0 | 0 | ||
S0340 | Other | SWOG | CL | 2/15/2007 | 0 | 0 | 0 | 0 | NO Credit Assigned | |
S0341 | Lung Non-Small Cell | SWOG | CL | 10/1/2005 | 1 | 0 | 0 | |||
S0342 | Lung Non-Small Cell | SWOG | CL | 8/1/2005 | 1 | 0 | 0 | |||
S0344 | Other | S0344 | SWOG | CL | 1/15/2007 | 1 | 0.5 | 0 | 0 | Cancer Control credit for QOL |
S0345 | Other | S0345 | SWOG | CL | 12/15/2006 | 1 | 0 | 0 | ||
S0346 | Sarcoma | S0346 | SWOG | CL | 12/1/2006 | 1 | 0 | 0 | 0 | |
S0347 | Breast | S0347 | SWOG | CL | 2/1/2006 | 1 | 0 | 0 | ||
S0349 | Lymphomas Non-Hodgkin's | SWOG | CL | 5/15/2006 | 1 | 0 | 0 | 0 | ||
S0350 | Lymphomas Non-Hodgkin's | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0351 | Genitourinary | SWOG | CL | 12/20/2006 | 1 | 0 | 0 | 0 | ||
S0353 | Genitourinary | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0354 | Genitourinary | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0355 | Other | SWOG | CL | 8/15/2006 | 1 | 0 | 0 | 0 | ||
S0356 | Head and Neck | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0400 | Genitourinary | SWOG | CL | 4/15/2006 | 1 | 0 | 0 | |||
S0408 | Gastrointestinal | SWOG | CL | 4/1/2007 | 1 | 0 | 0 | 0 | ||
S0410 | Lymphomas, Hodgkin's Disease | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0412 | Other | SWOG | CL | 5/15/2005 | 1 | 0 | 0 | |||
S0413 | Gastric | SWOG | CL | 5/15/2006 | 1 | 0 | 0 | |||
S0414 | Gastrointestinal | SWOG | CL | 9/1/2007 | 1 | 0 | 0 | 0 | ||
S0415 | Gastrointestinal | SWOG | CL | 1/1/2007 | 1 | 0 | 0 | |||
S0417 | Other | SWOG | CL | 6/15/2007 | 1 | 0 | 0 | 0 | ||
S0418 | Genitourinary | SWOG | CL | 5/1/2006 | 1 | 0 | 0 | 0 | ||
S0420 | Head and Neck | SWOG | CL | 3/1/2006 | 1 | 0 | 0 | 0 | ||
S0421 | Genitourinary | S0421 | SWOG | AC | 1 | 0.5 | 0 | 0 | 0.5 Cancer Control credit for QOL | |
S0423 | Sarcoma | SWOG | CL | 1/15/2007 | 1 | 0 | 0 | 0 | ||
S0424 | Lung Non-Small Cell | S0424 | SWOG | AC | 0 | 0.5 | 0 | 0 | ||
S0425 | Gastric | SWOG | CL | 1/15/2008 | 1 | 0 | 0 | 0 | ||
S0427 | Head and Neck | S0427 | SWOG | CL | 1/10/2007 | 1 | 0.5 | 0 | 0 | 0.5 Cancer Control credit for QOL |
S0429 | Lung Non-Small Cell | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0430 | Breast | SWOG | CL | 9/1/2007 | 1 | 0 | 0 | 0 | No CC Credit recommended | |
S0431 | Head and Neck | SWOG | CL | 1/10/2007 | 1 | 0 | 0 | 0 | ||
S0432 | Leukemia, Acute | S0432 | SWOG | CL | 2/15/2006 | 1 | 0 | 0 | ||
S0433 | Lymphomas Non-Hodgkin's | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0434 | Other | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0435 | Lung | SWOG | CL | 2/15/2007 | 1 | 0 | 0 | 0 | ||
S0437 | Active | 0 | 0.5 | 0.1 | 7 | 0.5 CC Credit for CCOPs is for registration (non-CCOPs will receive $1000). Follow-up is 0.1 CC credit for CCOPs ($100 for non-CCOP) for 7 years. Endpoint Data - 0.1 CC credit for CCOP ($100 for non-CCOP). | ||||
S0438 | Melanoma | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0500 | Breast | S0500 | SWOG | AC | 1 | 0 | 0 | 0 | Note: Arm A of the protocol is assigned Zero (i.e. NO) Credit. | |
S0500-ARM-A | Breast | S0500-ARM-A | SWOG | AC | 0 | 0 | 0 | 0 | Note: Arm A of the protocol is assigned Zero (i.e., NO) Credit. | |
S0501 | Lymphomas | SWOG | CL | 1/10/2007 | 1 | 0 | 0 | 0 | ||
S0502 | Gastrointestinal | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0505 | Sarcoma | S0505 | SWOG | CL | 9/15/2007 | 1 | 0 | 0 | 0 | |
S0506 | Head and Neck | SWOG | CL | 1/10/2007 | 1 | 0 | 0 | 0 | ||
S0508 | Melanoma | SWOG | CL | 1/1/2007 | 1 | 0 | 0 | 0 | ||
S0509 | Lung | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0511 | Breast | SWOG | CL | 1/10/2007 | 1 | 0 | 0 | 0 | ||
S0512 | Melanoma | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0514 | Gastric | SWOG | CL | 1/1/2007 | 1 | 0 | 0 | 0 | ||
S0515 | Lymphomas Non-Hodgkin's | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0517 | Lymphomas, Hodgkin's Disease | SWOG | CL | 8/1/2007 | 1 | 0 | 0 | 0 | ||
S0518 | Other | S0518 | SWOG | AC | 1 | 0 | 0 | 0 | ||
S0520 | Lymphomas | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0521 | Leukemia, Acute | S0521 | SWOG | AC | 1 | 0 | 0 | 0 | ||
S0526 | Lung | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0528 | Other | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0530 | Leukemia, Acute | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0533 | Lung Non-Small Cell | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0535 | Genitourinary | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0536 | Lung Non-Small Cell | SWOG | CL | 9/15/2007 | 1 | 0 | 0 | 0 | ||
S0600 | Gastrointestinal | S0600 | SWOG | AC | 1 | 0 | 0 | 0 | ||
S0601 | Lymphomas | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0605 | Leukemia, Acute | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0618 | Head and Neck | SWOG | CL | 1/1/2008 | 1 | 0 | 0 | 0 | ||
S0622 | Breast | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0635 | Lung | SWOG | AC | 1 | 0 | 0 | 0 | |||
S0636 | Lung Non-Small Cell | SWOG | AC | 1 | 0 | 0 | 0 | |||
S9615 | Genitourinary | SWOG | CL | 7/1/1998 | 1 | 0 | 0 | 0 | ||
S9617 | Leukemia, Acute | SWOG | CL | 9/1/1998 | 1 | 0 | 0 | 0 | ||
S9618 | Gynecologic | SWOG | CL | 9/15/1999 | 1 | 0 | 0 | 0 | ||
S9619 | Gynecologic | S9619 | SWOG | CL | 5/15/1998 | 1 | 0 | 0 | 0 | |
S9622 | Melanoma | SWOG | CL | 8/1/1998 | 1 | 0 | 0 | 0 | ||
S9623 | Breast | S9623 | SWOG | CL | 2/15/2001 | 1.1 | 0 | 0 | 0 | 0.1 Rx credit for Biomarker component of protocol |
S9624 | Brain | S9624 | SWOG | CL | 10/15/2000 | 1 | 0 | 0 | 0 | |
S9625 | Breast | SWOG | CL | 8/15/1998 | 1 | 0 | 0 | 0 | ||
S9626 | Intervention Study | Closed | 6/30/2000 | 0 | 0.7 | |||||
S9627 | Gastrointestinal | SWOG | CL | 3/1/1999 | 1 | 0 | 0 | 0 | ||
S9628 | Other | SWOG | CL | 3/15/2003 | 1 | 0 | 0 | 0 | ||
S9629 | Pancreatic | SWOG | CL | 3/15/1999 | 1 | 0 | 0 | 0 | ||
S9630 | Breast | S9630 | SWOG | CL | 12/15/2004 | 0.8 | 0.5 | 0 | 0 | 0.8 RX CREDIT (increased from 0.5 to 0.8 as of 6/01/99) & 0.5 CC CREDIT |
S9631 | Breast | S9631 | SWOG | CL | 3/1/2000 | 0.1 | 0 | 0 | 0 | |
S9632 | Intervention Study | Closed | 8/1/1998 | 0 | 0.7 | PILOT AND MAIN STUDY | ||||
S9635 | Gastrointestinal | SWOG | CL | 8/31/2000 | 1 | 0 | 0 | 0 | ||
S9700 | Pancreatic | SWOG | CL | 6/1/2001 | 1 | 0 | 0 | 0 | ||
S9701 | Gynecologic | S9701 | SWOG | CL | 12/1/2001 | 1 | 0 | 0 | 0 | |
S9702 | Breast | S9702 | SWOG | CL | 7/15/1999 | 0.1 | 0 | 0 | 0 | MARKER STUDY |
S9703 | Lymphomas | SWOG | CL | 3/1/1999 | 1 | 0 | 0 | 0 | ||
S9704 | Lymphomas Non-Hodgkin's | S9704 | SWOG | CL | 12/15/2007 | 1 | 0 | 0 | 0 | |
S9705 | Lung | SWOG | CL | 7/1/1998 | 1 | 0 | 0 | 0 | ||
S9706 | Leukemia, Chronic | SWOG | CL | 3/1/1999 | 1 | 0 | 0 | 0 | ||
S9708 | Head and Neck | SWOG | CL | 3/1/1999 | 1 | 0 | 0 | 0 | ||
S9711 | Leukemia, Acute | SWOG | CL | 8/15/1998 | 1 | 0 | 0 | 0 | ||
S9712 | Lung Non-Small Cell | SWOG | CL | 6/1/2000 | 1 | 0 | 0 | 0 | ||
S9713 | Lung | SWOG | CL | 8/1/1999 | 1 | 0 | 0 | 0 | ||
S9714 | Lung | SWOG | CL | 3/15/2000 | 1 | 0 | 0 | 0 | ||
S9716 | Other | SWOG | CL | 8/15/2000 | 1 | 0 | 0 | 0 | ||
S9717 | Gynecologic | SWOG | CL | 8/15/2000 | 1 | 0 | 0 | 0 | ||
S9718 | Lung | SWOG | CL | 6/15/1999 | 1 | 0 | 0 | 0 | ||
S9719 | Breast | SWOG | CL | 2/15/2001 | 0.1 | 0 | 0 | 0 | MARKER STUDY;PTS ENROLLED IN S9623 ELIGIBLE | |
S9720 | Gynecologic | SWOG | CL | 7/15/2000 | 1 | 0 | 0 | 0 | ||
S9800 | Lymphomas Non-Hodgkin's | SWOG | CL | 11/15/1998 | 1 | 0 | 0 | 0 | ||
S9801 | Head and Neck | SWOG | CL | 6/15/1999 | 1 | 0 | 0 | 0 | ||
S9802 | Sarcoma | S9802 | SWOG | CL | 3/15/1999 | 1 | 0 | 0 | 0 | |
S9803 | Multiple Myeloma | SWOG | CL | 12/15/1999 | 1 | 0 | 0 | 0 | ||
S9804 | Melanoma | SWOG | CL | 8/1/2001 | 1 | 0 | 0 | 0 | ||
S9805 | Other | SWOG | CL | 5/1/2000 | 1 | 0 | 0 | 0 | ||
S9806 | Lung Non-Small Cell | SWOG | CL | 11/15/1999 | 1 | 0 | 0 | 0 | ||
S9807 | CL | 2/15/2004 | 0 | 0 | 0 | NO CREDIT | ||||
S9809 | Genitourinary | SWOG | CL | 7/1/2001 | 1 | 0 | 0 | 0 | ||
S9810 | Other | SWOG | CL | 8/15/2000 | 1 | 0 | 0 | 0 | ||
S9811 | CNS, Pituitary | S9811 | SWOG | CL | 6/1/2005 | 1 | 0 | 0 | 0 | |
S9900 | Lung | S9900 | SWOG | CL | 7/15/2004 | 1 | 0 | 0 | 0 | |
S9901 | Lymphomas, Hodgkin's Disease | S9901 | SWOG | CL | 11/1/2001 | 1 | 0 | 0 | ||
S9902 | Head and Neck | SWOG | CL | 1/1/2001 | 1 | 0 | 0 | 0 | ||
S9903 | Brain | SWOG | CL | 6/15/2001 | 1 | 0 | 0 | 0 | COMMENT: TARGET ACCRUAL IS SHOWN AS THE MAX ( MIN WAS NOT STATED) | |
S9908 | Intervention Study | Closed | 4/15/2005 | 1 | Cancer Control credit increased from 0.5 to 1.0 as of June 1, 2003 | |||||
S9909 | Lung | SWOG | CL | 5/15/2001 | 0.1 | 0 | 0 | Companion to S9900 | ||
S9910 | Leukemia, Chronic | SWOG | AC | 0.1 | 0 | 0 | 0 | |||
S9911 | Lymphomas Non-Hodgkin's | SWOG | CL | 6/1/2000 | 1 | 0 | 0 | 0 | ||
S9912 | Gynecologic | SWOG | CL | 8/15/2005 | 1 | 0 | 0 | 0 | ||
S9914 | Lung | SWOG | CL | 6/15/2001 | 1 | 0 | 0 | |||
S9915 | Gastric | SWOG | CL | 9/1/2002 | 1 | 0 | 0 | |||
S9916 | Other | S9916 | SWOG | CL | 1/15/2003 | 1 | 0 | 0 | 0.8 CC credit deleted based on SWOG's request since the QOL component of the study funded via pharmaceutical contract | |
S9917 | Intervention Study | S9917 | Closed | 11/1/2006 | 1 | 0.3 | ||||
S9918 | Leukemia, Acute | SWOG | CL | 3/15/2001 | 1 | 0 | 0 | |||
S9920 | Leukemia, Acute | SWOG | CL | 10/15/2001 | 1 | 0 | 0 | |||
S9921 | Genitourinary | S9921 | SWOG | CL | 1/12/2007 | 1 | 0 | 0 | ||
S9922 | Other | SWOG | CL | 11/1/2001 | 1 | 0 | 0 | |||
S9923 | Gastrointestinal | SWOG | CL | 8/1/2001 | 1 | 0 | 0 | |||
S9924 | Gastrointestinal | SWOG | CL | 6/1/2001 | 1 | 0 | 0 | |||
S9925 | Lung | S9925 | AC | 0 | 0 | 0 | NO CREDIT | |||
S9926 | Gastrointestinal | SWOG | CL | 9/1/2003 | 1 | 0 | 0 | |||
S9927 | Breast | S9927 | SWOG | CL | 6/15/2003 | 1 | 0 | 0 | ||
SWOG-4B951 | Genitourinary | SWOG | CL | 3/28/2006 | 1 | 0 | 0 | |||
SWOG-8692 | Breast | INT-0075 | SWOG | CL | 7/15/1995 | 1 | 0 | 0 | 0 | |
SWOG-8710 | Genitourinary | INT-0080 | SWOG | CL | 7/1/1998 | 1.5 | 0 | 0 | 0 | HIGH PRIORITY APPROVAL |
SWOG-8711 | Descriptive | Closed | 6/1/1994 | 0 | 0.5 | |||||
SWOG-8733 | Genitourinary | CL | 2/15/1997 | 1 | 0 | 0 | 0 | |||
SWOG-8736 | Lymphomas Non-Hodgkin's | CL | 6/15/1995 | 1 | 0 | 0 | 0 | |||
SWOG-8745 | Intervention Study | Closed | 6/15/1990 | 0 | 0.7 | |||||
SWOG-8790 | Gynecologic | INT-0083 | SWOG | CL | 6/15/1999 | 1 | 0.1 | 0 | 0 | |
SWOG-8794 | Genitourinary | INT-0086 | CL | 1/1/1997 | 1 | 0 | 0 | 0 | ||
SWOG-8797 | Gynecologic | INT-0107 | SWOG | CL | 12/15/1996 | 1 | 0 | 0 | 0 | |
SWOG-8807 | Intervention Study | Closed | 12/1/1993 | 0 | 0 | 10.0 FOR START-UP + 100 SUBJ./ 15.0 FOR 200 SUBJ./ 20.0 FOR 300 SUBJ./ ADD'L 10.0 FOR COMPLETION | ||||
SWOG-8814 | Breast | INT-0100 | SWOG | CL | 8/1/1995 | 1 | 0 | 0 | 0 | |
SWOG-8819 | Lymphomas | AC | 0 | 0.1 | 0 | 0 | ||||
SWOG-8842 | Other | CL | 11/15/1992 | 1 | 0 | 0 | 0 | |||
SWOG-8855 | Head and Neck | CL | 9/1/2002 | 0 | 0 | 0 | 0 | DNA FLOW CYTOMETRY COMPANION STUDY | ||
SWOG-8861 | Intervention Study | Closed | 1/1/1992 | 0 | 0.5 | |||||
SWOG-8892 | Head and Neck | INT-0099 | SWOG | CL | 12/1/1995 | 1 | 0 | 0 | 0 | |
SWOG-8925 | Genitourinary | CL | 12/1/1995 | 1 | 0 | 0 | 0 | |||
SWOG-8947 | Other | AC | 0 | 0 | 0 | 0 | COMPANION STUDY TO SWOG RX PROTOCOLS: 8516,8809,8736, 8816 | |||
SWOG-8949 | Genitourinary | CL | 10/1/1998 | 1 | 0 | 0 | 0 | |||
SWOG-8952 | Lymphomas, Hodgkin's Disease | INT-0111 | CALGB | CL | 11/10/1995 | 1 | 0 | 0 | 0 | |
SWOG-8954 | Lymphomas | CL | 5/15/1997 | 1 | 0 | 0 | 0 | |||
SWOG-8990 | Gastrointestinal | INT-0103 | ECOG | CL | 1/31/1997 | 1 | 0 | 0 | 0 | |
SWOG-8993 | Other | CL | 5/1/1996 | 1 | 0 | 0 | 0 | |||
SWOG-8994 | Descriptive | Closed | 1/1/1997 | 0 | 0.5 | |||||
SWOG-9000 | Descriptive | Closed | 9/15/1993 | 0 | 0.1 | |||||
SWOG-9003 | Other | CL | 11/15/1997 | 1 | 0 | 0 | 0 | |||
SWOG-9005 | Brain | CL | 7/1/1998 | 1 | 0 | 0 | 0 | |||
SWOG-9006 | Gastrointestinal | CL | 11/1/1996 | 1 | 0 | 0 | 0 | |||
SWOG-9007 | Leukemia, Chronic | AC | 0 | 0 | 0 | 0 | CREDIT INCLUDED IN PRIMARY PROTOCOL | |||
SWOG-9008 | Gastrointestinal | INT-0116 | SWOG | CL | 7/15/1998 | 1.5 | 0 | 0 | 0 | HIGH PRIORITY APPROVAL; 1.0 CREDIT THRU 5/31/91; 1.5 STARTING 6/1/91 |
SWOG-9011 | Lymphomas, Hodgkin's Disease | CL | 12/1/1995 | 1.5 | 0 | 0 | 0 | |||
SWOG-9013 | Gastrointestinal | INT-0113 | RTOG | CL | 12/31/1995 | 1 | 0 | 0 | 0 | |
SWOG-9019 | Lung | CL | 12/1/1995 | 1 | 0 | 0 | 0 | |||
SWOG-9023 | Genitourinary | CL | 11/1/1998 | 0 | 0 | 0 | 0 | |||
SWOG-9032 | Leukemia, Chronic | CL | 3/1/1998 | 1 | 0 | 0 | 0 | |||
SWOG-9035 | Melanoma | CL | 11/15/1996 | 1 | 0 | 0 | 0 | |||
SWOG-9039 | Descriptive | Closed | 9/15/1994 | 0 | 0.3 | |||||
SWOG-9041 | Pilot Study | Closed | 11/1/1998 | 0 | 1 | 0.3 | 0.3 CREDIT FOR EACH ADDITIONAL YEAR | |||
SWOG-9045 | Descriptive | Closed | 1/15/1993 | 0 | 0.3 | |||||
SWOG-9058 | Lung | SWOG | CL | 6/1/1995 | 1 | 0 | 0 | 0 | ||
SWOG-9059 | Head and Neck | INT-0126 | ECOG | CL | 11/29/1999 | 1 | 0 | 0 | 0 | |
SWOG-9061 | Breast | INT-0121 | ECOG | CL | 8/3/1998 | 1.5 | 0 | 0 | 0 | HIGH PRIORITY APPROVAL; 1.0 CREDIT THRU 5/31/91; 1.5 STARTING 6/1/91 |
SWOG-9106 | Gynecologic | SWOG | CL | 11/15/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9109 | Genitourinary | SWOG | CL | 10/15/1996 | 1 | 0 | 0 | 0 | ||
SWOG-9111 | Melanoma | ECOG | CL | 6/1/1995 | 1.5 | 0 | 0 | 0 | HIGH PRIORITY APPROVAL; 1.0 THRU 5/31/91; 1.5 STARTING 6/1/91 | |
SWOG-9114/9232 | Breast | INT-0163 | CL | 5/29/1998 | 1.5 | 0.5 | 0 | 0 | HIGH-PRIORITY TRIAL--9232 IN THE QOL COMPONENT | |
SWOG-9118 | Gastrointestinal | CL | 11/15/1995 | 1 | 0 | 0 | 0 | |||
SWOG-9119 | Sarcoma | CL | 6/15/1998 | 1 | 0 | 0 | 0 | |||
SWOG-9120 | Other | CL | 7/1/1995 | 1 | 0 | 0 | 0 | |||
SWOG-9124 | Other | CL | 5/1/1995 | 1 | 0 | 0 | 0 | |||
SWOG-9126 | Leukemia, Chronic | CL | 3/1/1998 | 1 | 0 | 0 | 0 | |||
SWOG-9130 | Intervention Study | Closed | 8/17/1995 | 0 | 0.5 | |||||
SWOG-9132 | Gynecologic | CL | 5/15/1996 | 1 | 0 | 0 | 0 | |||
SWOG-9133 | Lymphomas, Hodgkin's Disease | CL | 4/24/2000 | 1 | 0 | 0 | 0 | |||
SWOG-9136 | Sarcoma | CL | 6/15/1998 | 0 | 0 | 0 | 0 | N.C.;COMPANION TO SWOG-9119 | ||
SWOG-9139 | Sarcoma | CL | 12/1/1996 | 1 | 0 | 0 | 0 | |||
SWOG-9140 | Genitourinary | CL | 12/1/1997 | 1 | 0 | 0 | 0 | |||
SWOG-9142 | Genitourinary | SWOG | CL | 2/1/1996 | 1 | 0 | 0 | 0 | ||
SWOG-9147 | Other | CL | 8/1/1996 | 1 | 0 | 0 | 0 | |||
SWOG-9148 | Other | CL | 6/1/1995 | 1 | 0 | 0 | 0 | |||
SWOG-9149 | Other | CL | 2/15/2001 | 1 | 0 | 0 | 0 | |||
SWOG-9158 | Lung | CL | 5/1/1996 | 1 | 0 | 0 | 0 | |||
SWOG-9201 | Head and Neck | RTOG | CL | 5/31/2000 | 1.5 | 0 | 0 | 0 | HIGH PRIORITY | |
SWOG-9205 | Other | CL | 10/1/2006 | 0 | 0 | 0 | 0 | CREDIT COVERED IN COMPANION PROTOCOL | ||
SWOG-9207 | Lung Non-Small Cell | SWOG | CL | 6/1/1995 | 1 | 0 | 0 | 0 | ||
SWOG-9208 | Lymphomas, Hodgkin's Disease | SWOG | CL | 4/24/2000 | 0 | 0.5 | 0 | 0 | QOL STUDY | |
SWOG-9208.FU | Lymphomas, Hodgkin's Disease | SWOG | CL | 5/31/2006 | 0.5 | 0 | 0 | Added 1X 0.5 Followup credit for continued data form submissions | ||
SWOG-9210 | Other | CL | 10/15/1997 | 1 | 0 | 0 | 0 | |||
SWOG-9212 | Gynecologic | SWOG | CL | 1/15/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9216 | Lung | INT-0131 | SWOG | CL | 4/26/1996 | 1 | 0 | 0 | 0 | |
SWOG-9217 | Intervention Study | Closed | 12/6/1996 | 0 | 1 | 0.3 | 1 CREDIT FOR YEAR ONE--0.3 CREDITS FOR EACH ADDITIONAL YR. | |||
SWOG-9217.EXT | Intervention Study | 9217.EXT | Closed | 6/30/2004 | 0.2 | |||||
SWOG-9217.WBC | Closed | 5/1/2005 | 0 | 0 | 0.1 | |||||
SWOG-9218 | Brain | SWOG | CL | 4/1/2002 | 0 | 0 | 0 | 0 | ||
SWOG-9219 | Lymphomas, Hodgkin's Disease | SWOG | CL | 8/1/1999 | 1 | 0 | 0 | 0 | ||
SWOG-9221 | Lung | I91-0001 | MDA | CL | 4/9/1997 | 0 | 1 | 0 | 0 | 1.0 CREDIT FOR YEAR ONE; 0.3 Followup Credit FOR ADDITIONAL YEARS. |
SWOG-9223 | Melanoma | CL | 8/15/1995 | 1 | 0 | 0 | 0 | |||
SWOG-9225 | Other | SWOG | CL | 6/1/1996 | 0 | 0 | 0 | 0 | ||
SWOG-9228 | Melanoma | CL | 9/1/1995 | 1 | 0 | 0 | 0 | |||
SWOG-9239 | Lymphomas | S9239 | ECOG | CL | 8/15/2000 | 1 | 0 | 0 | 0 | |
SWOG-9242 | Lung | SWOG | CL | 1/15/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9245 | Lymphomas | AC | 0 | 0 | 0 | 0 | ||||
SWOG-9246 | Lymphomas | CL | 12/1/1995 | 1 | 0 | 0 | 0 | |||
SWOG-9249 | Gynecologic | SWOG | CL | 7/1/1998 | 1 | 0 | 0 | 0 | ||
SWOG-9250 | Gastrointestinal | INT-0136 | ECOG | CL | 5/19/2000 | 1 | 0 | 0 | 0 | |
SWOG-9252 | Lung | INT-0115 | ECOG | CL | 12/1/1999 | 1.5 | 0 | 0 | 0 | |
SWOG-9300 | Leukemia, Chronic | SWOG | CL | 12/1/1999 | 1 | 0 | 0 | 0 | ||
SWOG-9303 | Gastrointestinal | INT-0130 | NCCTG | CL | 12/17/1996 | 1.5 | 0 | 0 | 0 | HIGH-PRIORITY |
SWOG-9304 | Gastrointestinal | INT-0144 | SWOG | CL | 8/1/2000 | 1 | 0 | 0 | 0 | |
SWOG-9305 | Head and Neck | CL | 5/15/1995 | 1 | 0 | 0 | 0 | |||
SWOG-9306 | Gastrointestinal | CALGB | CL | 10/15/1995 | 1 | 0 | 0 | 0 | ||
SWOG-9307 | Lung | SWOG | CL | 6/1/1996 | 1 | 0 | 0 | 0 | ||
SWOG-9310 | Lymphomas | INT-0143 | RTOG | CL | 12/1/1997 | 1 | 0 | 0 | 0 | |
SWOG-9312 | Genitourinary | SWOG | CL | 4/1/1998 | 1 | 0 | 0 | 0 | ||
SWOG-9313 | Breast | INT-0137 | SWOG | CL | 5/1/1997 | 1 | 0 | 0 | 0 | |
SWOG-9314 | Other | CL | 12/15/1995 | 0 | 0 | 0 | 0 | THIS IS A MARKER STUDY--CREDIT INCLUDED IN RX PROTOCOL | ||
SWOG-9316 | Genitourinary | SWOG | CL | 10/15/1996 | 0 | 0 | 0 | 0 | ||
SWOG-9318 | Gynecologic | SWOG | CL | 3/1/1999 | 1 | 0 | 0 | 0 | ||
SWOG-9320 | Lymphomas | SWOG | CL | 12/1/2000 | 1 | 0 | 0 | 0 | ||
SWOG-9321 | Multiple Myeloma | INT-0141 | SWOG | CL | 10/1/2000 | 1.5 | 0 | 0 | 0 | HIGH PRIORITY TRIAL |
SWOG-9323 | Lung Non-Small Cell | INT-0115 | ECOG | CL | 12/1/1996 | 0 | 0 | 0 | 0 | NON-TREATMENT |
SWOG-9324 | Gynecologic | SWOG | CL | 7/1/1997 | 0 | 0 | 0 | 0 | FUNDED BY BURROUGHS WELLCOME CO | |
SWOG-9325 | Melanoma | ECOG | CL | 6/1/1995 | 1 | 0 | 0 | 0 | ||
SWOG-9326 | Gynecologic | SWOG | CL | 5/19/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9327 | Pilot Study | Closed | 12/15/1997 | 0 | 0.5 | |||||
SWOG-9328 | Leukemia, Acute | SWOG | CL | 6/1/1996 | 1 | 0 | 0 | 0 | ||
SWOG-9331 | Other | ECOG | CL | 10/5/1995 | 0 | 0 | 0 | 0 | ||
SWOG-9332 | Breast | ECOG | CL | 9/29/1995 | 1 | 0.5 | 0 | 0 | ||
SWOG-9333 | Leukemia, Acute | SWOG | CL | 12/1/1998 | 1 | 0 | 0 | 0 | ||
SWOG-9336 | Lung Non-Small Cell | INT-0139 | RTOG | CL | 11/30/2001 | 1.5 | 0 | 0 | 0 | HIGH PRIORITY |
SWOG-9338 | Genitourinary | SWOG | CL | 9/1/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9339 | Head and Neck | SWOG | CL | 12/15/1995 | 1 | 0 | 0 | 0 | ||
SWOG-9340 | Brain | RTOG | CL | 4/15/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9341 | Lung | SWOG | CL | 9/15/1996 | 1 | 0 | 0 | 0 | ||
SWOG-9342 | Breast | SWOG | CL | 11/15/2003 | 0 | 0.5 | 0 | 0 | LATE CARDIAC EFFECTS | |
SWOG-9343 | Genitourinary | SWOG | CL | 1/15/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9346 | Genitourinary | INT-0162 | SWOG | AC | 1 | 0.5 | 0 | 0 | ||
SWOG-9347 | Breast | INT-0142 | ECOG | CL | 11/6/1997 | 1 | 0 | 0 | 0 | |
SWOG-9349 | Lymphomas | SWOG | CL | 1/15/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9350 | Melanoma | SWOG | CL | 11/13/1996 | 1 | 0 | 0 | 0 | ||
SWOG-9400 | Leukemia, Acute | SWOG | CL | 5/1/2000 | 1 | 0 | 0 | 0 | ||
SWOG-9401 | Gastrointestinal | NCCTG | CL | 9/10/1996 | 1 | 0 | 0 | 0 | ||
SWOG-9402 | Brain | INT-0149 | RTOG | CL | 1/29/2002 | 1 | 0 | 0 | 0 | |
SWOG-9403 | Genitourinary | ECOG | CL | 6/17/1998 | 1 | 0 | 0 | 0 | ||
SWOG-9405 | Gynecologic | SWOG | CL | 3/1/1999 | 0 | 0 | 0 | 0 | ||
SWOG-9407 | Genitourinary | SWOG | CL | 7/1/1996 | 1 | 0 | 0 | 0 | ||
SWOG-9410 | Breast | INT-0148 | CALGB | CL | 4/15/1997 | 1 | 0 | 0 | 0 | |
SWOG-9411 | Gastrointestinal | NCCTG | CL | 8/31/2001 | 0 | 0 | 0 | 0 | NO CREDIT- FUNDED UNDER A SEPARATE MECHANISM | |
SWOG-9412 | Breast | PBT-1 | ECOG | CL | 12/23/1997 | 1.5 | 0 | 0 | 0 | HIGH PRIORITY |
SWOG-9413 | Other | SWOG | CL | 3/15/1996 | 1 | 0 | 0 | 0 | ||
SWOG-9415 | Gastrointestinal | INT-0153 | SWOG | CL | 12/15/1999 | 1 | 0 | 0 | 0 | |
SWOG-9416 | Lung Non-Small Cell | INT-0160 | SWOG | CL | 8/1/1999 | 1 | 0 | 0 | 0 | |
SWOG-9419 | Gastrointestinal | SWOG | CL | 8/15/2001 | 0.1 | 0 | 0 | 0 | ||
SWOG-9420 | Gastrointestinal | SWOG | CL | 5/15/1999 | 1 | 0 | 0 | 0 | ||
SWOG-9424 | Lung | SWOG | CL | 12/1/1996 | 1 | 0 | 0 | 0 | ||
SWOG-9426 | Genitourinary | SWOG | CL | 6/1/2001 | 1 | 0 | 0 | 0 | PROTOCOL ORIGINALLY SUBMITTED IN JAN 1995; CREDIT ASSIGNED 12/96 FOR FUTURE ACCRUALS | |
SWOG-9427 | Other | SWOG | CL | 6/1/2000 | 1 | 0 | 0 | 0 | ||
SWOG-9428 | Genitourinary | SWOG | CL | 12/1/1999 | 0 | 0 | 0 | 0 | ||
SWOG-9429 | Lung Non-Small Cell | SWOG | CL | 9/1/1995 | 1 | 0 | 0 | 0 | ||
SWOG-9430 | Melanoma | SWOG-9430 | SWOG | CL | 11/15/2005 | 1 | 0 | 0 | 0 | |
SWOG-9431 | Melanoma | SWOG | CL | 12/15/2005 | 0.1 | 0 | 0 | 0 | ||
SWOG-9432 | Lymphomas | SWOG | CL | 1/15/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9433 | Lung | CALGB | CL | 3/31/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9437 | Lung | ECOG | CL | 10/1/1996 | 0 | 0.5 | 0 | 0 | ||
SWOG-9438 | Lymphomas, Hodgkin's Disease | SWOG | CL | 7/1/2004 | 1 | 0 | 0 | 0 | ||
SWOG-9442 | Other | T94-0086 | MSKCC | CL | 9/8/2003 | 1 | 0 | 0 | 0 | |
SWOG-9444 | Gastrointestinal | SWOG | CL | 9/1/2004 | 0.1 | 0 | 0 | 0 | ||
SWOG-9445 | Breast | S9445 | SWOG | CL | 10/1/1998 | 0 | 0 | 0 | 0 | |
SWOG-9446 | Head and Neck | RTOG | CL | 6/30/1999 | 0 | 1 | 0 | 0 | 1.0 CREDIT FOR YEAR ONE; 0.3 Followup Credit FOR ADDITIONAL YEARS. | |
SWOG-9448 | Gynecologic | SWOG | CL | 7/1/1998 | 0 | 0 | 0 | 0 | ||
SWOG-9449 | Other | INT-0156 | ECOG | CL | 2/27/1997 | 1 | 0 | 0 | 0 | |
SWOG-9451 | Head and Neck | SWOG | CL | 12/1/2001 | 1 | 0 | 0 | 0 | ||
SWOG-9452 | Genitourinary | INT-0159 | CALGB | CL | 7/15/1998 | 1 | 0.5 | 0 | 0 | 0.5 CC CREDIT FOR QOL |
SWOG-9455 | Genitourinary | SWOG | CL | 12/1/1998 | 1 | 0 | 0 | 0 | ||
SWOG-9457 | Genitourinary | SWOG | CL | 4/15/2000 | 1 | 0 | 0 | 0 | ||
SWOG-9458 | Genitourinary | SWOG | CL | 11/1/1998 | 0 | 0 | 0 | 0 | ||
SWOG-9460 | Intervention Study | Closed | 10/15/1999 | 0 | 1 | CREDIT FOR CCOPS/MBCCOP ACCRUALS ONLY | ||||
SWOG-9461 | Genitourinary | SWOG | CL | 6/15/1999 | 1 | 0 | 0 | 0 | ||
SWOG-9500 | Leukemia, Acute | SWOG | CL | 4/1/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9501 | Lymphomas | SWOG | CL | 2/15/1996 | 1 | 0 | 0 | 0 | ||
SWOG-9503 | Brain | NCCTG | CL | 6/18/1999 | 1 | 0 | 0 | 0 | ||
SWOG-9504 | Lung Non-Small Cell | SWOG | CL | 12/1/1998 | 1 | 0 | 0 | 0 | ||
SWOG-9505 | Melanoma | SWOG | CL | 8/15/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9507 | Intervention Study | Closed | 3/1/2000 | 0 | 1 | |||||
SWOG-9508 | Brain | ECOG | CL | 4/7/1999 | 1 | 0 | 0 | 0 | ||
SWOG-9509 | Lung Non-Small Cell | SWOG | CL | 1/1/1998 | 1 | 0.5 | 0 | 0 | 0.5 CC CREDIT FOR QOL | |
SWOG-9510 | Genitourinary | SWOG | CL | 8/15/1999 | 1 | 0 | 0 | 0 | ||
SWOG-9511 | Gastrointestinal | SWOG | CL | 11/15/1998 | 1 | 0 | 0 | 0 | ||
SWOG-9512 | Melanoma | E1694 | ECOG | CL | 10/15/1999 | 1 | 0 | 0 | 0 | |
SWOG-9514 | Breast | INT-0151 | ECOG | CL | 11/1/1999 | 1 | 0 | 0 | 0 | |
SWOG-9515 | Head and Neck | RTOG | CL | 4/28/2000 | 1 | 0 | 0 | 0 | ||
SWOG-9518 | Sarcoma | SWOG | CL | 10/15/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9519 | Head and Neck | SWOG | CL | 11/1/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9520 | Breast | SWOG | CL | 10/1/1997 | 1 | 0 | 0 | 0 | ||
SWOG-9521 | Gynecologic | SWOG | CL | 11/1/1998 | 0.1 | 0 | 0 | 0 |